Grabowska, A M <br/><br/>
Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models.  [electronic resource] 

 -  Regulatory peptides  Feb 2008 
 - 46-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-0115 
<br/><br/><label>Standard No.: </label>10.1016/j.regpep.2007.08.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antineoplastic Agents--chemistry<br/>Benzodiazepinones--chemistry<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Gastrointestinal Neoplasms--drug therapy<br/>Humans<br/>Molecular Structure<br/>Receptor, Cholecystokinin B--antagonists & inhibitors